Articles – Dedifferentiated Liposarcoma (DDL) A specially curated list of peer-reviewed articles discussing the latest advancements in the diagnosis and treatment of patients with DDL. Filter by Topic18FFDG PET/CTAbemaciclibAbstractAnlotinibApatinibBI 907828BiomarkerCase ReportCase StudyCDK4/6 inhibitorChemotherapyClinical TrialsCongressDalpiciclibDedifferentiated LiposarcomaDNA methylationDoxorubicinDurvalumabEribulinGradingGuidelinesImmunotherapyInhibitorKOL CommentaryLarotrectinibLiposarcomaMDM2MDM2–p53MDM2/CDK4 inhibitorsMRIMultidisciplinary Team (MDT)Myxoid liposarcomaNivolumabNTRKOlaratumabp53PalbociclibPazopanibPembrolizumabRadiotherapyRetroperitoneal LiposarcomaRetroperitoneal sarcomaRibociclibSelitrectinibSoft Tissue SarcomaSurgeryTrabectedinWell-Differentiated Liposarcoma Sorry, we couldn’t find any news. Facebook X (Twitter)